ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG

Discussion Board › Forums › Clinical Trials › ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG

Viewing 1 post (of 1 total)
  • Author
    Posts
  • May 18, 2017 at 5:40 pm #13350
    gavin
    Moderator

    ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG-120 vs placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation.

    http://abstracts.asco.org/199/AbstView_199_182088.html

    Please note that information regarding clinical trials is being provided for informational purposes only. The Cholangiocarcinoma Foundation does not endorse any specific clinical trial. Please discuss any questions you may have about clinical trials with your healthcare provider.

  • Author
    Posts
Viewing 1 post (of 1 total)
  • The forum ‘Clinical Trials’ is closed to new topics and replies.